🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
DNL
$DNLI
🔒 US EquitiesDenali Therapeutics Inc
AVG HISTORICAL GAP
+1.53%
MAX GAP RECORD
+18.06%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $DNLI
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$DNLI
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
+2.75%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
-1.37%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE) |
-1.31%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
+1.01%
|
| Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE) |
+0.72%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
-0.14%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE) |
+1.24%
|
| Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE) |
-1.02%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.2%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (4)
📖 Intelligence Summary
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗